Efficacy and safety of low dose oral prednisolone as compared to pulse intravenous methylprednisolone in managing moderate severe Graves’ orbitopathy: A randomized controlled trial

BACKGROUND: High dose oral prednisolone (100 mg/day) in Graves’ orbitopathy (GO) is limited by lesser response, and greater side-effects compared to intravenous (iv) methylprednisolone. Low dose oral prednisolone has not been evaluated in GO. This study aimed to evaluate the safety and efficacy of l...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, Ajitesh, Dutta, Deep, Ghosh, Sujoy, Mukhopadhyay, Pradip, Mukhopadhyay, Satinath, Chowdhury, Subhankar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366772/
https://www.ncbi.nlm.nih.gov/pubmed/25932389
http://dx.doi.org/10.4103/2230-8210.152770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366772/
https://www.ncbi.nlm.nih.gov/pubmed/25932389
http://dx.doi.org/10.4103/2230-8210.152770

Ejemplares similares